Menu
  • About Currax
    • Our Purpose and Values
    • Leadership
    • Corporate & Business Development
    • Company Culture
  • Products
    • Branded Products
      • CONTRAVE®
      • ONZETRA® Xsail®
      • SILENOR®
      • TREXIMET®
    • Generic Products
    • Innovation
      • About Clinical Trials
      • Currax Pharmaceuticals Clinical Trials
      • Independent Research and Educational Grants
  • Responsibility
    • Currax Compliance Program and Annual Declaration
    • Currax Code of Business Conduct and Ethics
    • Currax Data Subject Request
    • State Disclosures
  • MEDIA
    • Press Releases
    • Video Library
    • Currax in the News
  • Careers
    • Benefits
    • EEO Statement
    • Search Jobs
    • Disclaimer/Warning
  • Contact Us
Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
2020
February 27, 2020

Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations

Read more

Currax Pharmaceuticals LLC. All rights reserved. This information is intended only for residents of the United States.

  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Sitemap
  • Report An Adverse Event